Proposed research project for the WSMI general assembly in 2017

Parkinson, Bonny (Primary Chief Investigator)
Cutler, Henry (Chief Investigator)
Schroeder, Liz (Chief Investigator)

Macquarie Business School

Project: Research

Status	Finished
Effective start/end date	11/03/16 → 31/12/16

2019 Macquarie Business School Impact Competition, Enhancing medicine scheduling decisions through economics
Parkinson, B. (Recipient), 1 Jan 2020
Prize

File

4 Article
2 Meeting abstract
1 Commissioned report

Application of an economic evaluation approach to making regulatory decisions regarding access to medicines: advantages, challenges and recommendations
Parkinson, B. & Cutler, H., Apr 2022, In: Australian Health Review. 46, 2, p. 143-149 7 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
1 Citation (Scopus)

61 Downloads (Pure)
Cost-effectiveness of reclassifying triptans in Australia: Application of an economic evaluation approach to regulatory decisions
Parkinson, B., Gumbie, M., Cutler, H., Gauld, N., Mumford, V. & Haywood, P., Mar 2019, In: Value in Health. 22, 3, p. 293-302 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
5 Citations (Scopus)
Is reclassification of the oral contraceptive pill from prescription to pharmacist-only cost effective? Application of an economic evaluation approach to regulatory decisions
Gumbie, M., Parkinson, B., Cutler, H., Gauld, N. & Mumford, V., 1 Aug 2019, In: PharmacoEconomics. 37, 8, p. 1049-1064 16 p.
Research output: Contribution to journal › Article › peer-review
9 Citations (Scopus)

‘Not a clearcut case’: why a debate about the contraceptive pill is dividing the medical community
Parkinson, B.
12/11/21
1 item of Media coverage
Press/Media: Expert Comment
Over-the-counter contraceptive pill could save the health system $96 million a year
Parkinson, B. & Gumbie, M.
31/05/19 → 1/06/19
2 Media contributions
Press/Media: Expert Comment
Is reclassification of the oral contraceptive pill from prescription to pharmacist-only cost effective? Application of an economic evaluation approach to regulatory decisions
Parkinson, B., Gumbie, M., Cutler, H., Gauld, N. & Mumford, V.
23/05/19 → 31/05/19
4 items of Media coverage, 1 Media contribution
Press/Media: Research

3 Presentation
1 Invited talk

An economic evaluation framework to inform the scheduling of medicines in Australia
Parkinson, B. (Speaker)
30 May 2018 → 1 Jun 2018
Activity: Talk or presentation › Presentation
Is reclassifying the oral contraceptive pill to over-the-counter cost-effective?
Cutler, H. (Speaker)
Jul 2018
Activity: Talk or presentation › Invited talk
To down-schedule, or not to down-schedule, triptans in Australia?
Parkinson, B. (Speaker)
21 Sept 2017 → 22 Sept 2017
Activity: Talk or presentation › Presentation

Enhancing medicine scheduling decisions through economics
Parkinson, B. (Participant), Cutler, H. (Participant), Mutowo, M. (Participant), Gauld, N. (Participant), Mumford, V. (Participant) & Haywood, P. (Participant)
Impact: Policy impacts, Economy impacts, Quality of life impacts